최신임상강좌 : 불임 치료에서 난자공여술 = Recent Clinical Review : Oocyte Donation in Infertility Treatment

다국어 초록 (Multilingual Abstract)

Recent advances in assisted reproductive technology have been able to overcome the nearly all problems associated with traditional infertility factor. IVF and ET using donated oocyte has brought new hope to many couples who otherwise would remain childless, so oocyte donation can be the alternative treatment modality for specific fatal infertility patients. The high success rate of this procedure has led to its wide application in women with ovarian failure or dysfunction, at various ages and for various etiologies. Oocyte donation is also offered to patients who repeatedly fail to conceive with standard IVF. But there are many conflicting issues in this procedure such as moral, ethical, medical, legal problems. We review the technical aspects related with oocyte donation in infertility treatment and ethico-legal issue.

참고문헌 (Reference)

1 대한산부인과학회 인공수태시술 의료기관 심사소위원회, "조사보고서-한국 보조생식술의 현황:2002년" 48 : 2777-2796, 2005

2 이정호, "난자공여를 통한 체외수정 시술에서 성선자극호르몬유리호르몬 효능제 장기요법과 길항제 단기요법 사이의 임상 결과 비교" 30 : 95-103, 2003

3 Prapas Y, "The window for embryo transfer in oocyte donation cycles depends on the duration of progesterone therapy" 13 : 720-723, 1998

4 Lutjen P, "The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure" 307 : 174-5, 1984

5 Darder MC, "The effects of prior gravidity on the outcomes of ovum donor and own oocyte cycles" 65 : 578-582, 1996

6 Thong KJ, "The administration of the GnRH antagonist, cetrorelix, to oocyte donors simplifies oocyte donation" 18 : 1256-1258, 2003

7 Brinsden PR, "Textbook of In vitro fertilization and assisted reproduction The Bourn Hall guide to clinical and laboratory practice" Taylor & Francis 2005

8 Pe a JE, "Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles" 17 : 83-87, 2002

9 Karnis MF, "Risk of death in pregnancy achieved through oocyte donation in patient with Turner syndrome:a national survey" 80 : 498-501, 2003

10 Practice Committee of the American Society for Reproductive medicine, "Repetitive oocyte donation" 82 (82): 158-159, 2004

11 Svanberg AS, "Public opinion regarding oocyte donation in Sweden" 18 : 1107-1114, 2003

12 Smotrich DB, "Prognostic value of day 3 estradiol on in vitro fertilization outcome" 64 : 1136-1140, 1995

13 Van Steirteghem AC, "Pregnancy with a frozen-thawed embryo in a woman with primary ovarian failure" 317 : 113-, 1987

14 Trounson A, "Pregnancy established in an infertile recipient after transfer of a donated embryo fertilised in vitro" 286 : 835-8, 1983

15 Yovich JL, "PROST for ovum donation" 1 : 1209-10, 1987

16 Serhal PF, "Ovum donation-a simplified approach" 48 : 265-9, 1987

17 Soderstrom-Antilla V, "Oocyte donation in infertility treatment a review" 80 : 191-199, 2001

18 Asch R, "Oocyte donation and gamete intrafallopian transfer as treatment for premature ovarian failure" 1 : 687-, 1987

19 Isaza V, "Oocyte and embryo quality after coasting:the experience from oocyte donation" 17 : 1777-1782, 2002

20 Styne-Gross A, "Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation" 83 : 1629-1634, 2005

21 Bellver J, "Obesity and the risk of spontaneous abortion after oocyte donation" 79 : 1136-1140, 2003

22 Salha O, "Influence of body mass index and self administration of hCG in the outcome of IVF cycles: a prospective cohort study" 4 : 37-42, 2001

23 Hernandez ER, "Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles" 79 : 1461-1463, 2003

24 Prapas N, "GnRH agonist versus GnRH antagonist in oocyte donation cycles:a prospective randomized study" 20 : 1516-1520, 2005

25 Sheffer-Mimouni G, "Factors influencing the obstetric and perinatal outcome after oocyte donation" 17 : 2636-2640, 2002

26 Soares SR, "Extensive Clinical Experience. Age and Uterine Receptiveness: Predicting the Outcome of Oocyte Donation Cycles" 90 : 4399-4404, 2005

27 Frattarelli JL, "Evaluation of basal estradiol levels in assisted reproductive technology cycles" 74 : 518-524, 2000

28 Soderstrom-Antilla V, "Elective single embryo transfer yields good delivery rates in oocyte donation" 18 : 1858-1863, 2003

29 Ahuja KK, "Egg-sharing in assisted conception:ethical and practical considerations" 11 : 1126-1131, 1996

30 Borini A, "Effect of duration of estradiol replacement on the outcome of oocyte donation" 18 : 185-190, 2001

31 Greenfeld DA, "Disclosure decisions among known and anonymous oocyte donation recipients" 81 : 1565-1571, 2004

32 Licciardi FL, "Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization" 64 : 991-994, 1995

33 Wattanakumtornkul S, "Body mass index and uterine receptivity in the oocyte donation model" 80 : 336-340, 2003

34 Toner JP, "Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age" 55 : 784-91, 1991

35 Human Fertilisation, "Annual Report" HFEA 2001

36 Harris SE, "Analysis of donor heterogeneity as a factor affecting the clinical outcome of oocyte donation" 5 : 193-198, 2002

37 Barber R, "A report on 100 cycles of oocyte donation" 1018-22,